NCT00291616 - Efficacy Study of Thymosin alpha1 & Pegylated Interferon-alpha2a to Treat Chronic Hepatitis B | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 31, 2005

Primary Completion Date

August 31, 2008

Study Completion Date

August 31, 2008

Conditions

Chronic Hepatitis B

Interventions

DRUG

Pegylated Interferon-alpha2a

180 microgram s.c. injection weekly

DRUG

Thymosin alpha1 & Pegylated Interferon-alpha2a

Pegylated interferon 180 microgram s.c. injection weekly Thymosin 1.6 mg s.c. injection twice per week

Trial Locations (1)

Seoul National University Hospital, Seoul